NCT03443882View on ClinicalTrials.gov

Bioavailability of Astaxanthin Formulations

EARLY_PHASE1UnknownINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 25, 2018

Primary Completion Date

May 2, 2019

Study Completion Date

May 30, 2019

Conditions
Healthy Volunteers
Interventions
DIETARY_SUPPLEMENT

Astaxanthin

an oral dose form

Trial Locations (1)

52621

Bert W. Strassburger Lipid Center, Sheba Medical Center,, Tel Litwinsky

Sponsors
All Listed Sponsors
lead

Algatechnologies Ltd.

INDUSTRY

NCT03443882 - Bioavailability of Astaxanthin Formulations | Biotech Hunter | Biotech Hunter